| Name | progesterone receptors |
|---|---|
| Synonyms | NR3C3; PGR; PR; Progesterone receptor; Progesterone receptors |
| Name | DMPA |
|---|---|
| CAS |
| PubMed | Abstract | RScore(About this table) | |
|---|---|---|---|
| 16246667 | Ildgruben A, Sjoberg I, Hammarstrom ML, Backstrom T: Steroid receptor expression in vaginal epithelium of healthy fertile women and influences of hormonal contraceptive usage. Contraception. 2005 Nov;72(5):383-92. Epub 2005 Aug 9. RESULTS: Progesterone receptor expression was markedly down-regulated and significantly reduced in DMPA users compared to controls, COC and LNG users. |
82(1,1,1,2) | Details |
| 16311300 | Jain JK, Li A, Yang W, Minoo P, Felix JC: Effects of mifepristone on proliferation and apoptosis of human endometrium in new users of Hum Reprod. 2006 Mar;21(3):798-809. Epub 2005 Nov 25. RESULTS: Administration of mifepristone to DMPA-exposed endometrium for 1 week significantly increased endometrial expression of Ki-67 (MKI67), estrogen receptor (ER) alpha and progesterone receptors A and B (PRAB) and decreased the number of TUNEL-positive and caspase-3 (CASP3)-active cells in the endometrial stroma. |
7(0,0,1,2) | Details |
| 12678156 | Chotnopparatpattara P, Taneepanichskul S, Treratanachat S, Charuruks N: Relationship between progesterone receptor level in endometrium and bleeding pattern in depot medroxyprogesterone acetate users. J Med Assoc Thai. 2003 Feb;86(2):172-7. Bleeding disturbance is the major reason for discontinuation among depot medroxyprogesterone acetate (DMPA) users. |
2(0,0,0,2) | Details |
| 14668006 | Jain JK, Nicosia AF, Nucatola DL, Lu JJ, Kuo J, Felix JC: Mifepristone for the prevention of breakthrough bleeding in new starters of depo- Steroids. 2003 Nov;68(10-13):1115-9. Depo- (DMPA) is an effective injectable contraceptive with worldwide availability. Mifepristone is a progesterone receptor antagonist that has been demonstrated to decrease BTB caused by the levonorgestrel subdermal implant (Norplant). |
2(0,0,0,2) | Details |
| 14998949 | Sereepapong W, Chotnopparatpattara P, Taneepanichskul S, Markham R, Russell P, Fraser IS: Endometrial and estrogen receptors and bleeding disturbances in depot medroxyprogesterone acetate users. Hum Reprod. 2004 Mar;19(3):547-52. Epub 2004 Jan 29. BACKGROUND: Depot medroxyprogesterone acetate (DMPA) is a very popular hormonal contraceptive. Endometrial biopsies were collected for immunohistochemical study of progesterone receptor A plus B (PRAB) and B alone (PRB) and estrogen receptor alpha (ERalpha) and beta (ERbeta) expression. |
1(0,0,0,1) | Details |
| 17094978 | Jain JK, Li A, Yang W, Minoo P, Felix JC: Mifepristone alters expression of endometrial steroid receptors and their cofactors in new users of Fertil Steril. 2007 Jan;87(1):8-23. Epub 2006 Nov 7. OBJECTIVE: To evaluate the effect of mifepristone on the expression of endometrial steroid receptors and their co-factors in depot medroxyprogesterone acetate (DMPA) users. MAIN OUTCOME MEASURE (S): The expression of estrogen receptor subtypes alpha and beta (ERalpha and ERbeta), progesterone receptors A and B (PRAB and PRB), and androgen receptor messenger RNA and protein was detected by real-time polymerase chain reaction and immunohistochemistry, respectively. |
1(0,0,0,1) | Details |